Adverse events Length of · and
1 finding from 1 review
Adverse events Length of · and
It is very uncertain whether summary of findings: General medication review changes adverse events Length of compared with usual care (very low certainty).
1 finding from 1 review
Adverse events (serious) · carpal tunnel syndrome
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Serious adverse events ( · children with either displaced distal radius fracture with intact or displaced ulna fracture (both‐bone fracture), or minimally displaced…
1 finding from 1 review
Number of adverse events · people with primary sclerosing cholangitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ overall · adults with olecranon fractures
1 finding from 1 review
Adverse events assessed as reported in paper · children with nocturnal enuresis
1 finding from 1 review
Serious adverse events assessed using ICH‐GCP
It is very uncertain whether L‐ornithine L aspartate changes serious adverse events assessed using ICH‐GCP compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events at 1 month · people with acute non‐arteritic CRAO
1 finding from 1 review
Adverse events: infection · adults with chronic pain
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Adverse events: infection · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether cyclosporin changes adverse events: infection compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Adverse effects of antibiotics (skin rash) · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether rituximab/cyclosporin/prednisolone changes adverse events: skin rash compared with cyclosporin/prednisolone (very low certainty).
1 finding from 1 review
Serious adverse events at 'less than 3 months' · patients with suspected or diagnosed myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: thromboses · minimal change disease in adults with nephrotic syndrome
It is very uncertain whether intravenous ± oral steroids changes adverse events: thromboses compared with oral steroids alone (very low certainty).
1 finding from 1 review
Adverse events (all cause) · Men with COPD
Testosterone therapy showed no clear difference in adverse events (all cause) compared with placebo (low certainty).
1 finding from 1 review
Non‐serious adverse events assessed using ICH‐GCP
It is very uncertain whether L‐ornithine L aspartate changes non‐serious adverse events assessed using ICH‐GCP compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Somnolence · people with postburn pruritus
It is very uncertain whether doxepin cream changes adverse events (somnolence) compared with oral antihistamine (very low certainty).
1 finding from 1 review
Somnolence · people with postburn pruritus
Gabapentin may leads to lower adverse events (somnolence) compared with cetirizine (antihistamine) (low certainty).
1 finding from 1 review
Adverse effects: drowsiness (gabapentin alone) · people with postburn pruritus
Pregabalin may leads to lower adverse events (drowsiness) compared with cetirizine with pheniramine maleate (antihistamine) (low certainty).
1 finding from 1 review
Adverse events: hypotension · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether rituximab/cyclosporin/prednisolone changes adverse events: hypotension compared with cyclosporin/prednisolone (very low certainty).
1 finding from 1 review